Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: DB RCT for Specialized Phototherapy in Parkinson's Disease. [NA]

View source ↗

Summary

A double-blind randomized trial of specialized phototherapy for Parkinson's disease by PhotoPharmics, Inc. is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Specialized Phototherapy

Snippet

Sponsor: PhotoPharmics, Inc. | Conditions: Parkinson Disease | NA | Status: ACTIVE_NOT_RECRUITING